CTLA4_site_01 | SCGE Toolkit

SCGE Consortium Home | About SCGE Toolkit | Contact Us | Citing the Toolkit | License

Summary Sequence Viewer Related Editors Vector Off Targets Projects & Experiments

SCGE ID	10000000126
Lab ID	CTLA4_site_01
Source	lab IVT
Target Locus	CTLA4
Species	human
Description	Targets endogenous human locus
Guide Compatibility	SpyCas9

Target Sequence	GCACGTGGCCCAGCCTGCTG
Target Sequence + PAM	GCACGTGGCCCAGCCTGCTGNGG
Position	hg38/chr2:203870589-203870612

Spacer Sequence	GCACGUGGCCCAGCCUGCUG
Spacer Length	20
Modifications	none

Forward Primer	GGGAGGCTGGGGGTGTGGAGAG
Reverse Primer	CACCCGGACCTCAGTGGCTTTGC

Ivt Construct Source	Addgene
Vector Id	153997
Vector Name	pCRL01
Vector Description	Plasmid for single guide RNA IVT
Vector Type	plasmid
Annotated Map	addgene-plasmid-153997-sequence-304516

Detection Method	No. of sites detected
Change-seq	876
Guide-seq	13

Specificity Ratio	0.008

Publication Title
CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity. NCBI

This Guide: CTLA4_site_01 is being used ...

Project	Initiative	Contact PI
A Novel Human T-Cell Platform to Define Biological Effects of Genome Editing Experiments A novel human T cell platform to define biological adverse effects of genome editing	Biological Effects	Shengdar Q Tsai, PhD (St. Jude Children's Research Hospital)